Bio-Techne Long Term Debt

Bio-Techne (TECH) currently reports a long-term debt of $280M as of March 2026. That compares with $410M in the prior-year period — down 32.6% year over year. Use the charts on this page to explore Bio-Techne's long-term debt history and peer comparisons.

Bio-Techne's long-term debt decreased from $410M to $280M — a 32.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Techne reported $280M in long-term debt as of March 2026. That compares with $410M in the prior-year period — down 32.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Techne, and consider following TECH for alerts when major investors trade the stock.

Bio-Techne is classified in the Healthcare sector. On long-term debt, it currently shows $280M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TECH with unrelated industries.